Martin Preyer
Antibody Engineer | Molecular Biologist | Visionary Scientific Leader
- Role
- Executive Director Biotherapeutics at EvolveImmune Therapeutics
- Location
- Cambridge, MA, US
- LinkedIn followers
- 500 followers
About Martin Preyer
Visionary biologics drug discovery leader with deep expertise in antibody engineering, bispecific antibodies, antibody-drug conjugates, and a strong background in cancer and immuno-oncology• Driver of innovation with a track record of inventing bispecifics and multifunctional antibody platform technologies as supported by patents and publications• Proven manager successfully mentoring and developing individuals and leading multidisciplinary drug discovery teams from initiation to preclinical development• Excellent communicator and effective presenter to internal stakeholders, executive leadership teams as well as external audiences and investors• Recognized as outstanding collaborator in cross-functional biologics drug discovery teams across various therapeutic areas
Experience
Executive Director Biotherapeutics
Mar 2024 — Present
Education
University of Natural Resources and Life Sciences, Vienna (BOKU)
Diploma Engineer, Food Chemistry and Biotechnology
1995 — 2002
University of Natural Resources and Life Sciences, Vienna (BOKU)
Dr. nat. techn.
2002 — 2007
Skills
- Molecular Cloning
- Biochemistry
- Viral Vectors
- Genetics
- Life Sciences
- Antibodies
- Laboratory Skills
- Molecular Biology
- Fluorescence Microscopy
- Laboratory
- Drug Discovery
- Cell Biology
- Pharmacology
- Cell Culture
- Mammalian Cell Culture
- Protein Chemistry
- Cancer Biology
- Biotechnology
- Assay Development
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.